Loading stock data…
SEER
$1.86-0.09 (-4.62%)
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Seer, Inc. in the Healthcare sector is trading at $1.86. The stock is currently 23% below its 52-week high of $2.41, remaining 6.1% below its 200-day moving average. Technical signals show neutral RSI of 42 and bearish MACD signal, explaining why SEER maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 42) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.86
Potential Upside
5%
Whystock Fair Value$1.95
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Pr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$111.71M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.60
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-28.38%
Volume
Today's trading volume
1.02M
Recent News
Uncovering Opportunities: Penny Stocks To Watch In April 2026
Over the last 7 days, the United States market has experienced a significant downturn, dropping 29%, and is down 82% over the past year, though earnings are forecast to grow by 16% annually. In challenging market conditions like these, identifying stocks with strong financial fundamentals becomes crucial for investors seeking potential opportunities. Although "penny stocks" may seem like an outdated term, they continue to represent smaller or newer companies that can offer both affordability...
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks rose late Monday afternoon, with the NYSE Health Care Index up 0.2% and the State
Sector Update: Health Care Stocks Softer Monday Afternoon
Health care stocks declined Monday afternoon, with the NYSE Health Care Index down 0.2% and the Stat
Thermo Fisher Stock May Benefit Following Collaboration With PRECISE
TMO teams up with PRECISE on a major proteomics study, expanding its role in large biobank projects and precision medicine initiatives.
Bullish Seer Insiders Loaded Up On US$5.29m Of Stock
Over the last year, a good number of insiders have significantly increased their holdings in Seer, Inc. ( NASDAQ:SEER...